Kolexia
Delecroix Valerie Oncologie médicale
Delecroix Valerie
Oncologie médicale
Clinique Mutualiste De L'estuaire
Saint-Nazaire, France
45 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Tumeurs de l'ovaire Carcinome épithélial de l'ovaire Métastase tumorale Prédisposition génétique à une maladie Fatigue Cardiopathies Seconde tumeur primitive Récidive tumorale locale

Collaborateurs

Voir plus
Saliou Marie-Gabrielle
Saliou Marie-Gabrielle
Clinique Mutualiste De L'estuaire, Saint-Nazaire, France
Chatellier Thierry
Chatellier Thierry
Clinique Mutualiste De L'estuaire, Saint-Nazaire, France
Cojocarasu Oana
Cojocarasu Oana
Centre Hospitalier du Mans, Le Mans, France
Drouet Franck
Drouet Franck
Clinique Mutualiste De L'estuaire, Saint-Nazaire, France

Industries

Voir plus
AstraZeneca
3 collaboration(s)
Dernière en 2022
Novartis
3 collaboration(s)
Dernière en 2021
MSD
2 collaboration(s)
Dernière en 2023
Pfizer
2 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
304P ESR1 mutations and outcomes in BRCA1/2 or PALB2 germline mutation carriers receiving first line aromatase inhibitor + palbociclib (AI+P) for metastatic breast cancer (MBC) in the PADA-1 trial
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
Quality of advanced ovarian cancer surgery: A French assessment of ESGO quality indicators.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology   11 août 2020
Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study.
Annals of oncology : official journal of the European Society for Medical Oncology   12 juin 2020
Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients.
International journal of cancer   01 août 2019
Determinants of severe chronic fatigue among epithelial ovarian cancer survivors: A GINECO VIVROVAIRE study.
2018 ASCO Annual Meeting I   01 juin 2018
GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients.
Oncotarget   26 février 2018
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study.
Annals of oncology : official journal of the European Society for Medical Oncology   29 janvier 2018
Long term quality of life among epithelial ovarian cancer patients: The GINECO case/control VIVROVAIRE Study
Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8-12 September 2017, Madrid, Spain   01 septembre 2017
Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Breast cancer research : BCR   22 août 2017
Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort.
NPJ breast cancer   23 février 2017